Skip to main content
  • EN
  • FI
  • SV
Login

Main navigation

  • About FinnGen
    • Summary & Goals
      • Goals
      • FinnGen 1-2
      • FinnGen 3 (2023-2027)
    • Consortium
      • Partners
      • Funding
      • Governance
      • Steering Committee Members
      • Scientific Committee Members
      • Teams
      • Collaboration
    • Impact
      • National Impact
      • National Research Network
      • Open Science
      • Research Highlights
    • Why Finland?
      • Biobank Network
      • Legislative Review
      • National Registries
      • Population Genetic History
      • Industry partners
    • Mediabank
  • For Researchers
    • Research Activities
      • Core Analyses
      • Disease Task Forces
      • Expansion Areas
      • Global Initiatives
    • Cohort and Data
      • Register Data
      • Basic Characteristics
      • Clinical Endpoints
      • Genetic Data
      • Laboratory Values
      • Other Phenotype Data
      • Recruitment
      • Other Biological Data
      • Data Available
    • Accessing Data, Results & Tools
      • Access results
      • Computing environment
      • How we collaborate
      • Partner researchers
      • Public data releases
      • Tools
    • Publications
    • Researcher FAQ
  • For Participants
    • Participation
      • Study Participants
      • Biobanks' Role in FinnGen
      • Biobank Contact Information
      • Recall Studies
      • Questions and answers
    • Data Protection and Security
      • Data Protection
      • Data Security
      • Sample & Data Flow
      • Data Protection Statement
    • Significance
      • Videos
  • News
  • EN
  • FI
  • SV

Links

  • PheWeb
  • Risteys
  • Meta-analysis Pheweb (FG-MVP-UKBB)
  • FinnGen handbook
  • Meta-analysis Pheweb (FG-UKBB)
  • Coding variant browser
  • Endpoint Browser
  • FinnGen GITHUB
  • LAVAA volcano plot
  • Multiple Manhattan Plot
  • Variant Cluster Corrector
  • Variant Cluster Call Corrector
Breadcrumb
  1. Home

L3MBTL2 as a novel therapeutic target for trigeminal neuralgia: evidence from integrated TWAS, multi-tissue MR, and experimental validation

Submitted by Anna Hakala on Mon, 12/15/2025 - 10:34
  • Read more about L3MBTL2 as a novel therapeutic target for trigeminal neuralgia: evidence from integrated TWAS, multi-tissue MR, and experimental validation

Serum iron levels as a risk factor for Osteoporosis-Related pathological fractures

Submitted by Anna Hakala on Mon, 12/15/2025 - 10:32
  • Read more about Serum iron levels as a risk factor for Osteoporosis-Related pathological fractures

Genetic insights into colorectal cancer pathogenesis: a multi-omics and immunity perspective

Submitted by Anna Hakala on Mon, 12/15/2025 - 10:31
  • Read more about Genetic insights into colorectal cancer pathogenesis: a multi-omics and immunity perspective

Causal relationship between hypertension and cancer: a two‑sample bidirectional Mendelian randomization study

Submitted by Anna Hakala on Mon, 12/15/2025 - 10:02
  • Read more about Causal relationship between hypertension and cancer: a two‑sample bidirectional Mendelian randomization study

The association between magnesium levels and gout: evidence from Mendelian randomization, a Chinese cross-sectional study, and NHANES analysis

Submitted by Anna Hakala on Mon, 12/15/2025 - 10:00
  • Read more about The association between magnesium levels and gout: evidence from Mendelian randomization, a Chinese cross-sectional study, and NHANES analysis

Application of Mendelian randomization to explore metabolic pathways in colorectal cancer

Submitted by Anna Hakala on Mon, 12/15/2025 - 09:58
  • Read more about Application of Mendelian randomization to explore metabolic pathways in colorectal cancer

From genetic causality to druggable targets: A multiomics framework identifies ZSCAN16 in gout pathogenesis

Submitted by Anna Hakala on Mon, 12/15/2025 - 09:56
  • Read more about From genetic causality to druggable targets: A multiomics framework identifies ZSCAN16 in gout pathogenesis

Exploring the Potential Causal Relationship of Galectin Levels and Gynecologic Cancers: A Two-Sample Mendelian Randomization Study

Submitted by Anna Hakala on Mon, 12/15/2025 - 09:55
  • Read more about Exploring the Potential Causal Relationship of Galectin Levels and Gynecologic Cancers: A Two-Sample Mendelian Randomization Study

Cathepsins effect on diffuse large B cell lymphoma risk: A Mendelian randomization study

Submitted by Anna Hakala on Mon, 12/15/2025 - 09:45
  • Read more about Cathepsins effect on diffuse large B cell lymphoma risk: A Mendelian randomization study

Plasma proteins and osteosarcoma: Mendelian randomization analysis and targeted therapeutic discovery

Submitted by Anna Hakala on Mon, 12/15/2025 - 09:43
  • Read more about Plasma proteins and osteosarcoma: Mendelian randomization analysis and targeted therapeutic discovery

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 31
  • Page 32
  • Page 33
  • Page 34
  • Current page 35
  • Page 36
  • Page 37
  • Page 38
  • Page 39
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Contact us

Contact person
finngen-info@helsinki.fi
Follow us on Bluesky
@finngen.bsky.social
Follow us on LinkedIn
https://www.linkedin.com/company/finngen/

Lead organisations

The University of Helsinki is the organization responsible for the FinnGen research project. The Finnish consortium partners include all Finnish public biobanks and their background organisations, so the project covers the whole of Finland. All partners are listed on this page.

About the website

Accessibility statement